SlideShare a Scribd company logo
Pneumonia Cases
Dr. Sameh Ahmad Muhamad abdelghany
Lecturer Of Clinical Pharmacology
Mansura Faculty of medicine
Pneumonia
CAS(1)
CHIEF COMPLAINT
4
 Cough and fever for four days.
HISTORY
5
 Mr. Alcot is a 68 year old man who developed a tough, productive cough four
days prior to being seen by a physician. The sputum is thick and yellow with
streaks of blood. He developed a fever, shaking, chills and malaise along with
the cough. One day ago he developed pain in his right chest that intensifies
with inspiration. The patient lost 7 kilograms over the past few months but
claims he did not lose his appetite. "I just thought I had the flu." Past history
reveals that he had a chronic smoker's cough for "10 or 15 years" which he
describes as being mild, non-productive and occurring most often in the early
morning. He smoked 2 packs of cigarettes per day for the past 50 years.
PHYSICAL EXAMINATION
6
 The patient is an elderly man who appears tired weak and underweight. His
complexion is pale. He coughs continuously. Sitting in a chair, he leans to his right
side, holding his right chest with his left arm. Vital signs are as follows: blood pressure
152/90, apical heart rate 112/minute and regular, respiratory rate 24/minute and
somewhat labored, temperature 39.2 ° Celsius. Both lungs are resonant by percussion
with one exception: the right mid-anterior and right mid-lateral lung fields are dull.
Auscultation reveals bilateral diminished vesicular breath sounds. Bronchial breath
sounds, rhonchi and late inspiratory crackles (are heard) in the area of the right mid-
anterior and right mid-lateral lung fields. The remainder of the lung fields is clear.
Percussion and auscultation of the heart reveals no significant abnormality.
LABORATORY
7
 WBC 17,000/mm3; neutrophils 70%, bands 15%,
lymphocytes 15%.
COURSE OF ILLNESS
8
 Following a chest x-ray PA
view and Lateral which
revealed an acute pneumonia
in the right middle lobe, the
patient was treated with
antibiotics as an outpatient.
COURSE OF ILLNESS
9
 During the 10 days of treatment the patient's fever abated
and he felt somewhat better. A post-treatment (follow up)
chest x-ray reveals a right hilar mass. Sputum cytology
demonstrates atypical cells.
Questions
10
 Q1:Identify the problems from the history?
 Q2:Identify and explain the significance of physical findings?
 Q3:Review the lab findings. What is your diagnosis?
 Q4:What do you understand by the terms "hospital acquired"
and "community acquired " pneumonia.? Which type of
pneumonia does our patient have?
 Q5:What organisms are likely to be causing his
pneumonia?
Questions
11
 Q6: How is the specific diagnosis established?
 Q7: What antimicrobial agents would you prescribe for this
patient? Would you use or avoid penicillin, and why?
 Q8:What is the duration of treatment?
Answer of Question 1
12
 Acute febrile illness
 Cough with Yellow sputum, with streaking of blood
 Pain in chest
 Shaking chills
 weight loss
 Chronic bronchitis
 Smoker
 Hypertension
Back
Answer of Question 2
13
 BP, Temp, Respiratory rate
 Labored breathing
 Supraclavicular node
 Dullness with bronchial breathing over right mid anterior
lung field.
Back
Answer of Question 3
14
 Lobar Pneumonia
Back
Answer of Question 4
15
 Oropharyngeal colonization is different in the community
and hospital setting.
 This makes a difference in the etiology of pneumonia.
 This patient has community acquired pneumonia.
Back
Answer of Question 5
16
 The patient has community-acquired pneumonia.
 The most common organisms are
1. Streptococcus pneumoniae (30%)
2. Hemophilus influenzae (10%)
3. Mycoplasma pneumoniae (10%)
4. Chlamydia pneumoniae (8%)
5. influenza virus (7%)
6. Legionella species (3%)
7. gram negative Enterobacteriaceae (3%)
8. Chlamydia psittaci (1%)
Back
Answer of Question 6
17
 Gram stain: The diagnosis is suggested by the
demonstration of large numbers of PMN’s and gram-
positive diplococci in a gram stained sputum specimen.
 Sputum culture: The diagnosis is confirmed by
identification of Streptococcus pneumoniae in sputum
culture.
Back
Answer of Question 7
18
 Penicillin has been the standard drug to treat pneumonococcal
pneumonia. Procaine penicillin G, amoxicillin, cefazolin, and
erythromycin are effective.
 Trimethoprim-sulfamethoxazole should be avoided as up to 20%
isolated from day care centers are resistant.
 In penicillin – allergic patients, erythromycin is an alternative.
 The emergence of penicillin resistant strains is of great concern .
Where the incidence of resistance of high, Ceftriaxone or
erythromycin are the agents of choice.
Back
Answer of Question 8
19
 The length of treatment will vary with the severity of illness and the
presence of underlying disease.
 Generally, 7-10 days of antibiotic should be sufficient.
 Pneumococci are no longer detected in the sputum within several hours
of the first dose of penicillin.
 Dramatic symptomatic improvement in 24 hours
 The lack of lung destruction and complete resolution of pathologic
changes on recovery, coupled with the dramatic response to penicillin,
allow for a relatively short duration of treatment.
Back
CAS(2)
Scenario
21
A 15 year old female with a history of hay fever develops fever,
headache and malaise for 4 days followed by a nonproductive
cough and scratchy throat. Despite chicken soup and orange juice,
the cough and fever persist, and her mother drags her to your
office. On examination, her temperature is 38.3° celsius, pulse 90
beats/min, BP 110/70, respiratory rate 20 beats/min Physical
examination is unremarkable except for scattered rales over the
left lower lung, and small bullae in her left tympanic membrane.
Chest x-ray reveals a patchy left lower lobe infiltrate. At your
request, she makes a great effort but is unable to produce sputum.
Questions
22
 Q1:What is the type of pneumonia likely to have?
 Q2:What is "atypical pneumonia"?
 Q3:What is the differential diagnosis of atypical pneumonia?
 Q4: If the causative organism was Mycoplasma pneumonia,
What antimicrobial agent(s) would you use ?
Answer of Question 1
23
 Atypical pneumonia.
Back
Answer of Question 2
24
 The term "atypical pneumonia" is applied to non-lobar
patchy or interstitial infiltrates on chest x-ray where the
causative organism is not identified on gram stain or
culture of sputum.
 Often they are not toxic, do not have shivers and do not
seek medical attention. "Walking Pneumonia“
Back
Answer of Question 3
25
 The pathogens causing atypical pneumonia include
o Mycoplasma pneumoniae
o Chlamydia psittaci
o Chlamydia pneumoniae
o Coxiella burnetii
o Legionella pneumophila
o viruses including influenza A and B, parainfluenza, adenovirus and
respiratory syncytial virus.
Back
Answer of Question 4
26
 Erythromycin and tetracycline are equally effective in treatment of M.
pneumoniae infection. They shorten the course of infection but do not
eliminate the carrier state.
 Clarithromycin and azithromycin are also effective but much more
expensive.
 Quinolones such as ciprofloxacin have in vitro efficacy against
mycoplasma, but are expensive and contra-indicated in children.
 Since mycoplasmas lack a cell wall, beta-lactam antibiotics are
ineffective for treatment.
 Therapy is generally continued for 2-3 weeks, as relapses can occur in
up to 10% cases
Back
CAS(3)
Scenario
28
A 35 year alcoholic male with a history of seizures is admitted
with a three week history of fever, generalized weakness, poor
appetite, and cough productive of green, foul - smelling sputum.
On physical examination, the temperature is 37.9 celsius degrees.
Pulse is 96 beats per minute, respiratory rate is 20 breaths per
minute, and BP is 120/80 mm. There are many missing teeth with
gingivitis and dental caries. He has rales and decreased breath
sounds over the right base. Chest x-ray shows consolidation in the
superior segment of the right lower lobe.
Questions
29
 Q1: What type of infection is suggested by his fowl smelling
sputum?
 Q2: What organisms could be responsible for this patient's
pneumonia?
 Q3: How would you treat this patient?
 Q4: What organisms might be the cause of a hospital acquired
aspiration pneumonia?
Answer of Question 1
30
 Anaerobic infection.
Back
Answer of Question 2
31
 Peptostreptococcus sp.
 Bacteroides sp. (B. melanogenicus, B. intermedius)
 Fusobacterium sp.
Back
Answer of Question 3
32
 Antibiotic therapy is the key treatment for anaerobic pulmonary infections.
 Drug of choice: Clindamycin
 Alternative agents: Penicillin, Ampicillin/sulbactam, or
Amoxicillin/clavulanic acid
 Duration of therapy will depend on radiographic clearance, and may range
as long as 2-4 months.
 Postural drainage is an important component of therapy.
Back
Answer of Question 4
33
 Patients with nosocomial aspiration pneumonia are more likely to have a
mixed aerobic-anaerobic infection, in which the aerobic component
(gram-negative bacilli) predominates.
 Aerobic organisms: Klebsiella , Enterobacter , Serratia , E. coli ,
Pseudomonas aeruginosa, Staphylococcus aureus ,
 Anaerobic organisms: Peptostreptococcus sp. , Bacteroides sp. (B.
melanogenicus, B. intermedius) , Fusobacterium sp.
 Antibiotics
o Drug of choice: Clindamycin + aminoglycoside
o Alternative agents: Ticarcillin/clavulanate, or Imipenem, or Piperacillin, or
Mezlocillin
Back
T H A N K Y O U !
A N Y Q U E S T I O N S ?

More Related Content

What's hot

COPD presentation
COPD presentationCOPD presentation
COPD presentation
Kathy Chow
 

What's hot (20)

CA Cervix Case presentation
CA Cervix Case presentationCA Cervix Case presentation
CA Cervix Case presentation
 
Osteoarthritis - Case Based Discussion
Osteoarthritis -  Case Based DiscussionOsteoarthritis -  Case Based Discussion
Osteoarthritis - Case Based Discussion
 
cerebrovascular accident
 cerebrovascular accident cerebrovascular accident
cerebrovascular accident
 
COPD presentation
COPD presentationCOPD presentation
COPD presentation
 
Diabetic Ketoacidosis Case presentation
Diabetic Ketoacidosis Case presentation Diabetic Ketoacidosis Case presentation
Diabetic Ketoacidosis Case presentation
 
Surviving Sepsis in Pregnancy
Surviving Sepsis in PregnancySurviving Sepsis in Pregnancy
Surviving Sepsis in Pregnancy
 
Digoxin Toxicity
Digoxin Toxicity Digoxin Toxicity
Digoxin Toxicity
 
Pediatrics/Case Report: Sickle Cell Disease
Pediatrics/Case Report: Sickle Cell DiseasePediatrics/Case Report: Sickle Cell Disease
Pediatrics/Case Report: Sickle Cell Disease
 
case presentation on generalized epileptic seizures in pediatrics
case presentation on generalized epileptic seizures in pediatricscase presentation on generalized epileptic seizures in pediatrics
case presentation on generalized epileptic seizures in pediatrics
 
COPD case presentation
COPD case presentation COPD case presentation
COPD case presentation
 
Mortality meeting jun july 2019
Mortality meeting jun july 2019Mortality meeting jun july 2019
Mortality meeting jun july 2019
 
Pregnancy Induced Hypertension - Pre eclampsia
Pregnancy Induced Hypertension - Pre eclampsiaPregnancy Induced Hypertension - Pre eclampsia
Pregnancy Induced Hypertension - Pre eclampsia
 
Formula for calculating the required dose of iron sucrose
Formula for calculating the required dose of iron sucroseFormula for calculating the required dose of iron sucrose
Formula for calculating the required dose of iron sucrose
 
A CASE PRESENTATION ON COPD,CORPULMONALE
A CASE PRESENTATION ON COPD,CORPULMONALEA CASE PRESENTATION ON COPD,CORPULMONALE
A CASE PRESENTATION ON COPD,CORPULMONALE
 
Case study myasthenia gravis
Case study myasthenia gravisCase study myasthenia gravis
Case study myasthenia gravis
 
CASE PRESENTATION ON ARF
CASE PRESENTATION ON ARFCASE PRESENTATION ON ARF
CASE PRESENTATION ON ARF
 
CASE PRESENTATION ON BRONCHIOLITIS
CASE PRESENTATION ON BRONCHIOLITISCASE PRESENTATION ON BRONCHIOLITIS
CASE PRESENTATION ON BRONCHIOLITIS
 
ARDS (Case study)
ARDS (Case study)ARDS (Case study)
ARDS (Case study)
 
205804404 ischemic-stroke-case-study
205804404 ischemic-stroke-case-study205804404 ischemic-stroke-case-study
205804404 ischemic-stroke-case-study
 
OP poisoning case presentation.pptx
OP poisoning case presentation.pptxOP poisoning case presentation.pptx
OP poisoning case presentation.pptx
 

Similar to Pneumoniatutor 180316220436

Real-World Boards Cases ,PULMCCM
Real-World Boards Cases ,PULMCCMReal-World Boards Cases ,PULMCCM
Real-World Boards Cases ,PULMCCM
Saher Farghly
 
Pneumonia, definition, symptoms, causes and cure
Pneumonia, definition, symptoms, causes and curePneumonia, definition, symptoms, causes and cure
Pneumonia, definition, symptoms, causes and cure
azadabubaker
 
CAP 2010 Guidelines
CAP 2010 GuidelinesCAP 2010 Guidelines
CAP 2010 Guidelines
cap_0009
 
1 topic 1 differential diagnosis of pneumonia in children. complications of ...
1 topic 1  differential diagnosis of pneumonia in children. complications of ...1 topic 1  differential diagnosis of pneumonia in children. complications of ...
1 topic 1 differential diagnosis of pneumonia in children. complications of ...
MaeRose2
 

Similar to Pneumoniatutor 180316220436 (20)

Hoang's pulm review
Hoang's pulm reviewHoang's pulm review
Hoang's pulm review
 
Clinical Cases Study for Meningitis
Clinical Cases Study for  Meningitis Clinical Cases Study for  Meningitis
Clinical Cases Study for Meningitis
 
Real-World Boards Cases ,PULMCCM
Real-World Boards Cases ,PULMCCMReal-World Boards Cases ,PULMCCM
Real-World Boards Cases ,PULMCCM
 
Community Acquired Pneumonia .pdf
Community Acquired Pneumonia .pdfCommunity Acquired Pneumonia .pdf
Community Acquired Pneumonia .pdf
 
Pneumonia, definition, symptoms, causes and cure
Pneumonia, definition, symptoms, causes and curePneumonia, definition, symptoms, causes and cure
Pneumonia, definition, symptoms, causes and cure
 
April 24th ppt
April 24th pptApril 24th ppt
April 24th ppt
 
April 24th ppt
April 24th pptApril 24th ppt
April 24th ppt
 
Antimicrobial regimen selection
Antimicrobial regimen selectionAntimicrobial regimen selection
Antimicrobial regimen selection
 
Pneumonia mksap 18
Pneumonia mksap 18Pneumonia mksap 18
Pneumonia mksap 18
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Update management of CAP
Update management of CAPUpdate management of CAP
Update management of CAP
 
Krok 2 - 2013 Question Paper (General Medicine)
Krok 2 - 2013 Question Paper (General Medicine)Krok 2 - 2013 Question Paper (General Medicine)
Krok 2 - 2013 Question Paper (General Medicine)
 
Pediatric pneumonia
Pediatric pneumoniaPediatric pneumonia
Pediatric pneumonia
 
MCQs & Case Discussion- 2
MCQs & Case Discussion- 2MCQs & Case Discussion- 2
MCQs & Case Discussion- 2
 
CAP 2010 Guidelines
CAP 2010 GuidelinesCAP 2010 Guidelines
CAP 2010 Guidelines
 
Pneumonia
Pneumonia Pneumonia
Pneumonia
 
1 topic 1 differential diagnosis of pneumonia in children. complications of ...
1 topic 1  differential diagnosis of pneumonia in children. complications of ...1 topic 1  differential diagnosis of pneumonia in children. complications of ...
1 topic 1 differential diagnosis of pneumonia in children. complications of ...
 
A Case Presentation on Pneumonia
A Case Presentation on PneumoniaA Case Presentation on Pneumonia
A Case Presentation on Pneumonia
 
Diagnosis & Mangement of Community-Acquired Pneumonia, Hospital Acquired Pneu...
Diagnosis & Mangement of Community-Acquired Pneumonia, Hospital Acquired Pneu...Diagnosis & Mangement of Community-Acquired Pneumonia, Hospital Acquired Pneu...
Diagnosis & Mangement of Community-Acquired Pneumonia, Hospital Acquired Pneu...
 
A M Treat. Pneum.
A M Treat. Pneum.A M Treat. Pneum.
A M Treat. Pneum.
 

Recently uploaded

BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
Cell structure slideshare.pptx Unlocking the Secrets of Cells: Structure, Fun...
Cell structure slideshare.pptx Unlocking the Secrets of Cells: Structure, Fun...Cell structure slideshare.pptx Unlocking the Secrets of Cells: Structure, Fun...
Cell structure slideshare.pptx Unlocking the Secrets of Cells: Structure, Fun...
ananyagirishbabu1
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
SasikiranMarri
 

Recently uploaded (20)

Storage_of _Bariquin_Components_in_Storage_Boxes.pptx
Storage_of _Bariquin_Components_in_Storage_Boxes.pptxStorage_of _Bariquin_Components_in_Storage_Boxes.pptx
Storage_of _Bariquin_Components_in_Storage_Boxes.pptx
 
Importance of Diet on Dental Health.docx
Importance of Diet on Dental Health.docxImportance of Diet on Dental Health.docx
Importance of Diet on Dental Health.docx
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
 
Digital Healthcare: The Future of Medical Consultations
Digital Healthcare: The Future of Medical ConsultationsDigital Healthcare: The Future of Medical Consultations
Digital Healthcare: The Future of Medical Consultations
 
Nose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptx
Nose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptxNose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptx
Nose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptx
 
#cALL# #gIRLS# In Chhattisgarh ꧁❤8901183002❤꧂#cALL# #gIRLS# Service In Chhatt...
#cALL# #gIRLS# In Chhattisgarh ꧁❤8901183002❤꧂#cALL# #gIRLS# Service In Chhatt...#cALL# #gIRLS# In Chhattisgarh ꧁❤8901183002❤꧂#cALL# #gIRLS# Service In Chhatt...
#cALL# #gIRLS# In Chhattisgarh ꧁❤8901183002❤꧂#cALL# #gIRLS# Service In Chhatt...
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
Occupational Therapy Management for Parkinson's Disease - Webinar 2024
Occupational Therapy Management for Parkinson's Disease - Webinar 2024Occupational Therapy Management for Parkinson's Disease - Webinar 2024
Occupational Therapy Management for Parkinson's Disease - Webinar 2024
 
Healthcare Companion Robots: Key Features and Functionalities, Benefits, Chal...
Healthcare Companion Robots: Key Features and Functionalities, Benefits, Chal...Healthcare Companion Robots: Key Features and Functionalities, Benefits, Chal...
Healthcare Companion Robots: Key Features and Functionalities, Benefits, Chal...
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
 
Cell structure slideshare.pptx Unlocking the Secrets of Cells: Structure, Fun...
Cell structure slideshare.pptx Unlocking the Secrets of Cells: Structure, Fun...Cell structure slideshare.pptx Unlocking the Secrets of Cells: Structure, Fun...
Cell structure slideshare.pptx Unlocking the Secrets of Cells: Structure, Fun...
 
Virtual Health Platforms_ Revolutionizing Patient Care.pdf
Virtual Health Platforms_ Revolutionizing Patient Care.pdfVirtual Health Platforms_ Revolutionizing Patient Care.pdf
Virtual Health Platforms_ Revolutionizing Patient Care.pdf
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
 
Contact mE 👙👨‍❤️‍👨 (89O1183OO2) 💘ℂall Girls In MOHALI By MOHALI 💘ESCORTS GIRL...
Contact mE 👙👨‍❤️‍👨 (89O1183OO2) 💘ℂall Girls In MOHALI By MOHALI 💘ESCORTS GIRL...Contact mE 👙👨‍❤️‍👨 (89O1183OO2) 💘ℂall Girls In MOHALI By MOHALI 💘ESCORTS GIRL...
Contact mE 👙👨‍❤️‍👨 (89O1183OO2) 💘ℂall Girls In MOHALI By MOHALI 💘ESCORTS GIRL...
 
QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020
 
Enhancing-Patient-Centric-Clinical-Trials.pdf
Enhancing-Patient-Centric-Clinical-Trials.pdfEnhancing-Patient-Centric-Clinical-Trials.pdf
Enhancing-Patient-Centric-Clinical-Trials.pdf
 
Master the Art of Yoga with Joga Yoga Training
Master the Art of Yoga with Joga Yoga TrainingMaster the Art of Yoga with Joga Yoga Training
Master the Art of Yoga with Joga Yoga Training
 
What can we really do to give meaning and momentum to equality, diversity and...
What can we really do to give meaning and momentum to equality, diversity and...What can we really do to give meaning and momentum to equality, diversity and...
What can we really do to give meaning and momentum to equality, diversity and...
 
PhRMA Vaccines Deck_05-15_2024_FINAL.pptx
PhRMA Vaccines Deck_05-15_2024_FINAL.pptxPhRMA Vaccines Deck_05-15_2024_FINAL.pptx
PhRMA Vaccines Deck_05-15_2024_FINAL.pptx
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
 

Pneumoniatutor 180316220436

  • 1. Pneumonia Cases Dr. Sameh Ahmad Muhamad abdelghany Lecturer Of Clinical Pharmacology Mansura Faculty of medicine
  • 4. CHIEF COMPLAINT 4  Cough and fever for four days.
  • 5. HISTORY 5  Mr. Alcot is a 68 year old man who developed a tough, productive cough four days prior to being seen by a physician. The sputum is thick and yellow with streaks of blood. He developed a fever, shaking, chills and malaise along with the cough. One day ago he developed pain in his right chest that intensifies with inspiration. The patient lost 7 kilograms over the past few months but claims he did not lose his appetite. "I just thought I had the flu." Past history reveals that he had a chronic smoker's cough for "10 or 15 years" which he describes as being mild, non-productive and occurring most often in the early morning. He smoked 2 packs of cigarettes per day for the past 50 years.
  • 6. PHYSICAL EXAMINATION 6  The patient is an elderly man who appears tired weak and underweight. His complexion is pale. He coughs continuously. Sitting in a chair, he leans to his right side, holding his right chest with his left arm. Vital signs are as follows: blood pressure 152/90, apical heart rate 112/minute and regular, respiratory rate 24/minute and somewhat labored, temperature 39.2 ° Celsius. Both lungs are resonant by percussion with one exception: the right mid-anterior and right mid-lateral lung fields are dull. Auscultation reveals bilateral diminished vesicular breath sounds. Bronchial breath sounds, rhonchi and late inspiratory crackles (are heard) in the area of the right mid- anterior and right mid-lateral lung fields. The remainder of the lung fields is clear. Percussion and auscultation of the heart reveals no significant abnormality.
  • 7. LABORATORY 7  WBC 17,000/mm3; neutrophils 70%, bands 15%, lymphocytes 15%.
  • 8. COURSE OF ILLNESS 8  Following a chest x-ray PA view and Lateral which revealed an acute pneumonia in the right middle lobe, the patient was treated with antibiotics as an outpatient.
  • 9. COURSE OF ILLNESS 9  During the 10 days of treatment the patient's fever abated and he felt somewhat better. A post-treatment (follow up) chest x-ray reveals a right hilar mass. Sputum cytology demonstrates atypical cells.
  • 10. Questions 10  Q1:Identify the problems from the history?  Q2:Identify and explain the significance of physical findings?  Q3:Review the lab findings. What is your diagnosis?  Q4:What do you understand by the terms "hospital acquired" and "community acquired " pneumonia.? Which type of pneumonia does our patient have?  Q5:What organisms are likely to be causing his pneumonia?
  • 11. Questions 11  Q6: How is the specific diagnosis established?  Q7: What antimicrobial agents would you prescribe for this patient? Would you use or avoid penicillin, and why?  Q8:What is the duration of treatment?
  • 12. Answer of Question 1 12  Acute febrile illness  Cough with Yellow sputum, with streaking of blood  Pain in chest  Shaking chills  weight loss  Chronic bronchitis  Smoker  Hypertension Back
  • 13. Answer of Question 2 13  BP, Temp, Respiratory rate  Labored breathing  Supraclavicular node  Dullness with bronchial breathing over right mid anterior lung field. Back
  • 14. Answer of Question 3 14  Lobar Pneumonia Back
  • 15. Answer of Question 4 15  Oropharyngeal colonization is different in the community and hospital setting.  This makes a difference in the etiology of pneumonia.  This patient has community acquired pneumonia. Back
  • 16. Answer of Question 5 16  The patient has community-acquired pneumonia.  The most common organisms are 1. Streptococcus pneumoniae (30%) 2. Hemophilus influenzae (10%) 3. Mycoplasma pneumoniae (10%) 4. Chlamydia pneumoniae (8%) 5. influenza virus (7%) 6. Legionella species (3%) 7. gram negative Enterobacteriaceae (3%) 8. Chlamydia psittaci (1%) Back
  • 17. Answer of Question 6 17  Gram stain: The diagnosis is suggested by the demonstration of large numbers of PMN’s and gram- positive diplococci in a gram stained sputum specimen.  Sputum culture: The diagnosis is confirmed by identification of Streptococcus pneumoniae in sputum culture. Back
  • 18. Answer of Question 7 18  Penicillin has been the standard drug to treat pneumonococcal pneumonia. Procaine penicillin G, amoxicillin, cefazolin, and erythromycin are effective.  Trimethoprim-sulfamethoxazole should be avoided as up to 20% isolated from day care centers are resistant.  In penicillin – allergic patients, erythromycin is an alternative.  The emergence of penicillin resistant strains is of great concern . Where the incidence of resistance of high, Ceftriaxone or erythromycin are the agents of choice. Back
  • 19. Answer of Question 8 19  The length of treatment will vary with the severity of illness and the presence of underlying disease.  Generally, 7-10 days of antibiotic should be sufficient.  Pneumococci are no longer detected in the sputum within several hours of the first dose of penicillin.  Dramatic symptomatic improvement in 24 hours  The lack of lung destruction and complete resolution of pathologic changes on recovery, coupled with the dramatic response to penicillin, allow for a relatively short duration of treatment. Back
  • 21. Scenario 21 A 15 year old female with a history of hay fever develops fever, headache and malaise for 4 days followed by a nonproductive cough and scratchy throat. Despite chicken soup and orange juice, the cough and fever persist, and her mother drags her to your office. On examination, her temperature is 38.3° celsius, pulse 90 beats/min, BP 110/70, respiratory rate 20 beats/min Physical examination is unremarkable except for scattered rales over the left lower lung, and small bullae in her left tympanic membrane. Chest x-ray reveals a patchy left lower lobe infiltrate. At your request, she makes a great effort but is unable to produce sputum.
  • 22. Questions 22  Q1:What is the type of pneumonia likely to have?  Q2:What is "atypical pneumonia"?  Q3:What is the differential diagnosis of atypical pneumonia?  Q4: If the causative organism was Mycoplasma pneumonia, What antimicrobial agent(s) would you use ?
  • 23. Answer of Question 1 23  Atypical pneumonia. Back
  • 24. Answer of Question 2 24  The term "atypical pneumonia" is applied to non-lobar patchy or interstitial infiltrates on chest x-ray where the causative organism is not identified on gram stain or culture of sputum.  Often they are not toxic, do not have shivers and do not seek medical attention. "Walking Pneumonia“ Back
  • 25. Answer of Question 3 25  The pathogens causing atypical pneumonia include o Mycoplasma pneumoniae o Chlamydia psittaci o Chlamydia pneumoniae o Coxiella burnetii o Legionella pneumophila o viruses including influenza A and B, parainfluenza, adenovirus and respiratory syncytial virus. Back
  • 26. Answer of Question 4 26  Erythromycin and tetracycline are equally effective in treatment of M. pneumoniae infection. They shorten the course of infection but do not eliminate the carrier state.  Clarithromycin and azithromycin are also effective but much more expensive.  Quinolones such as ciprofloxacin have in vitro efficacy against mycoplasma, but are expensive and contra-indicated in children.  Since mycoplasmas lack a cell wall, beta-lactam antibiotics are ineffective for treatment.  Therapy is generally continued for 2-3 weeks, as relapses can occur in up to 10% cases Back
  • 28. Scenario 28 A 35 year alcoholic male with a history of seizures is admitted with a three week history of fever, generalized weakness, poor appetite, and cough productive of green, foul - smelling sputum. On physical examination, the temperature is 37.9 celsius degrees. Pulse is 96 beats per minute, respiratory rate is 20 breaths per minute, and BP is 120/80 mm. There are many missing teeth with gingivitis and dental caries. He has rales and decreased breath sounds over the right base. Chest x-ray shows consolidation in the superior segment of the right lower lobe.
  • 29. Questions 29  Q1: What type of infection is suggested by his fowl smelling sputum?  Q2: What organisms could be responsible for this patient's pneumonia?  Q3: How would you treat this patient?  Q4: What organisms might be the cause of a hospital acquired aspiration pneumonia?
  • 30. Answer of Question 1 30  Anaerobic infection. Back
  • 31. Answer of Question 2 31  Peptostreptococcus sp.  Bacteroides sp. (B. melanogenicus, B. intermedius)  Fusobacterium sp. Back
  • 32. Answer of Question 3 32  Antibiotic therapy is the key treatment for anaerobic pulmonary infections.  Drug of choice: Clindamycin  Alternative agents: Penicillin, Ampicillin/sulbactam, or Amoxicillin/clavulanic acid  Duration of therapy will depend on radiographic clearance, and may range as long as 2-4 months.  Postural drainage is an important component of therapy. Back
  • 33. Answer of Question 4 33  Patients with nosocomial aspiration pneumonia are more likely to have a mixed aerobic-anaerobic infection, in which the aerobic component (gram-negative bacilli) predominates.  Aerobic organisms: Klebsiella , Enterobacter , Serratia , E. coli , Pseudomonas aeruginosa, Staphylococcus aureus ,  Anaerobic organisms: Peptostreptococcus sp. , Bacteroides sp. (B. melanogenicus, B. intermedius) , Fusobacterium sp.  Antibiotics o Drug of choice: Clindamycin + aminoglycoside o Alternative agents: Ticarcillin/clavulanate, or Imipenem, or Piperacillin, or Mezlocillin Back
  • 34. T H A N K Y O U ! A N Y Q U E S T I O N S ?